| |
|
|
|
About Medigus
|
|
Medigus is a medical device company specializes in developing
innovative endoscopic procedures and devices.
Medigus is a pioneer developer of a unique proprietary endoscopic device for the treatment of GERD, one of the most common chronic diseases in the western world.
In addition, based on its proprietary technologies, Medigus designs and manufactures endoscopy systems, for parter companies, including major players in the medical device industry.
Medigus has an advanced technology platform that includes all necessary elements for performing a wide range of endoscopic procedures. The platform includes various types of rigid, semi-flexible and flexible video endoscopes, as well as respective endoscopy suites.
|
|
|
Mission Statment
|
| |
Our mission is to develop and commercialize state-of-the-art endoluminal procedures and their related endoscopy systems that will meet the most stringent requirements in the medical device field.
Our primary goal is to make significant and sustainable contribution to physicians' efforts to perform advanced endoscopic procedures, while significantly reducing the level of discomfort experienced by patients that undergo existing more-invasive procedures.
|
| |
|
Board of Directors
|
|
|
Medigus' Board of Directors combines experienced executives with extensive background in managing and developing emerging companies. Medigus' Board of Directors is comprised of reputable people with broad business experience in the financial and medical device markets.
|
|
|
|
|
| Back to top |
|
|
|
|
|
|
|
Over the last thirty five years Mr. Streit has been active in multinational business development involving investments, corporate finance, private equity, international trade and transfer of technologies. Mr. Streit served as the managing director of Yeda, the commercial arm of the Weizmann Institute, one of the world leading Life Sciences centres. Mr. Strient also served as the managing director of Dizengoff West Africa, a subsidiary of Balton CP based in Watford UK
Member of the Board of Retalix, a NASDAQ traded company; Member of the Board of Governors of Tel Aviv University and Tel Aviv Foundation; Member the executive committee of Israel British Chamber of Commerce.
BA in Economics and Political Science, Hebrew U., Israel. MBA in Finance and International Marketing, Wharton, U. of Pennsylvania, US.
|
|
| |
 |
|
|
| |
|
Medigus On TASE
|
|
|
On March 8, 2006, Medigus completed a successful IPO on the Tel-Aviv Stock Exchange.
Details in the Hebrew language as to the share trade, as well as publications made by the company can be found on the official web-site of the Tel-Aviv Stock Exchange.
Thank You Note:
Medigus would like to thank the institutional and private investors for their support and for the trust that they placed in the company during the IPO. In addition, the company would like to thank the underwriters, legal consultants, accountants as well as all the other people that supported the company during the IPO process.
|
|
|
Career
|
|
|
Thank you for your interest in career opportunities with Medigus Ltd.
Medigus Ltd. seeks individuals with strong business and technical skills. If you are interested in the career opportunities available at Medigus, please send us your resume.
Again, thank you for your interest.
|
|
|
Apply Here:
jobs@medigus.com
|
|
|
|
There are
search results for
found in
:
|
|
|
|
|
|
|
|
There are
search results for
found in
:
|
|
|
|
|
|
|
|
There are
search results for
found in
:
|
|
|
|
|
|
|
|
There are
search results for
found in
:
|
|
|
|
|
|
|
|
There are
search results for
found in
:
|
|
|
|
|
|
|
|
|
|
|
| |
|
Contact Details
|
Medigus Ltd.
7A Industrial Park,
P.O. Box 3030, Omer,
Israel 84965
Tel : +972 8646 6880
Fax: +972 8646 6770
E-Mail: info@medigus.com
Web: www.medigus.com
|
|
|